As on Thursday, Tango Therapeutics Inc (NASDAQ: TNGX) started slowly as it slid -11.03% to $3.63, before settling in for the price of $4.08 at the close. Taking a more long-term approach, TNGX posted a 52-week range of $2.70-$13.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 132.62% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -11.20%. This publicly-traded company’s shares outstanding now amounts to $102.20 million, simultaneously with a float of $59.92 million. The organization now has a market capitalization sitting at $389.92 million. At the time of writing, stock’s 50-day Moving Average stood at $6.19, while the 200-day Moving Average is $8.36.
Tango Therapeutics Inc (TNGX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Tango Therapeutics Inc’s current insider ownership accounts for 44.22%, in contrast to 56.77% institutional ownership. According to the most recent insider trade that took place on Nov 18 ’24, this organization’s Director bought 10,000 shares at the rate of 3.78, making the entire transaction reach 37,800 in total value, affecting insider ownership by 31,250. Preceding that transaction, on Nov 14 ’24, Company’s Director bought 10,000 for 3.62, making the whole transaction’s value amount to 36,200. This particular insider is now the holder of 21,250 in total.
Tango Therapeutics Inc (TNGX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
Tango Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -11.20% and is forecasted to reach -1.43 in the upcoming year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Let’s observe the current performance indicators for Tango Therapeutics Inc (TNGX). It’s Quick Ratio in the last reported quarter now stands at 8.00. The Stock has managed to achieve an average true range (ATR) of 0.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.99.
In the same vein, TNGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.17, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.43 at the market close of one year from today.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Through scrutinizing the latest numbers posted by the [Tango Therapeutics Inc, TNGX], it can be observed that its last 5-days Average volume of 2.57 million was better the volume of 1.01 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 79.00% While, its Average True Range was 0.53.
Raw Stochastic average of Tango Therapeutics Inc (TNGX) in the period of the previous 100 days is set at 9.98%, which indicates a major fall in contrast to 35.84% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 227.69% that was higher than 109.33% volatility it exhibited in the past 100-days period.
